Showing results (41-50 of 382) with videos related to
Sort By:
Pageof 39
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 3, 2014
Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directionsAbhishek Tripathi, Charles G Drake, Lauren C HarshmanAdvances in Immunology|May 30, 2006
Mechanisms of immune evasion by tumorsCharles G Drake, Elizabeth Jaffee, Drew M PardollInteractive Cardiovascular and Thoracic Surgery|December 1, 2009
Parabolic resection for mitral valve repairDaniel H Drake, Charles G Drake, Dino RecchiaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Immunotherapy for brain cancer: recent progress and future promiseChristopher M Jackson, Michael Lim, Charles G DrakeUrologic Oncology|April 15, 2011
Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumorNeda Sadeghi, Gina M Badalato, Max Kates, et al.BJU International|May 9, 2012
Secondary bladder cancer after upper tract urothelial carcinoma in the US populationMax Kates, Gina M Badalato, Mantu Gupta, et al.Current Urology Reports|October 10, 2024
Strategies to Improve Clinical Outcomes and Patient Experience Undergoing Transurethral Resection of Bladder TumorSadra Sepehri, Michael E Rezaee, Zhuo Tony Su, et al.The Journal of Urology|August 19, 2011
Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or lessMax Kates, Gina M Badalato, Max Pitman, et al.Urologic Oncology|March 18, 2014
Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks modelHiten D Patel, Max Kates, Phillip M Pierorazio, et al.Urologic Oncology|December 24, 2021
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancerSean A Fletcher, Trinity J Bivalacqua, Otis W Brawley, et al.Pageof 39